EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
21 avr. 2023 08h00 HE | EDAP TMS S.A.
  Meeting to Showcase EDAP’s Focal One® Robotic High Intensity Focused Ultrasound (HIFU) Platform for the Management of Prostate Cancer LYON, France, April 21, 2023 -- EDAP TMS SA (Nasdaq:...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
10 avr. 2023 08h00 HE | EDAP TMS S.A.
Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Webcast scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 -- EDAP...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
06 avr. 2023 08h00 HE | EDAP TMS S.A.
Allows for market launch of the only micro-ultrasound platform for precision prostate biopsies LYON, France, April 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
30 mars 2023 06h30 HE | EDAP TMS S.A.
Record full-year 2022 total revenue of EUR 55.1 million ($58.0 million) increased 25.1% over full-year 2021Full-year HIFU revenue was EUR 15.6 million (USD 16.4 million), an increase of 57.7% as...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
21 mars 2023 16h30 HE | EDAP TMS S.A.
  Results demonstrate salvage treatment free survival rate (STFS) at 30 months of 90.1% in the HIFU-treated arm versus 86.8% in patients who underwent radical prostatectomy (RP) The HIFU...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
09 mars 2023 08h00 HE | EDAP TMS S.A.
LYON, France, March 9, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the...
Defensive Cyber Operations for Space
EIGHT COMPANIES JOIN CATALYST ACCELERATOR'S DEFENSIVE CYBER OPERATIONS FOR SPACE COHORT
17 févr. 2023 10h57 HE | Catalyst Accelerator
COLORADO SPRINGS, COLORADO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The Catalyst Accelerator is kicking off its 11th cohort. Eight small businesses will come together from across the United States for...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
14 févr. 2023 09h00 HE | EDAP TMS S.A.
Record full-year 2022 total preliminary unaudited revenue of €55.1 million ($58.0 million) represents an increase of 25.1% over full-year 2021, driven by 58.1% HIFU growth Record Q4 2022 total...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
31 janv. 2023 08h00 HE | EDAP TMS S.A.
Focal One® HIFU treatment resulted in significant improvements in endometriosis symptoms and quality of life (QoL)Positive safety profile with 96.7% of patients with no or non-significant adverse...
Egide: 2022 Revenue
Egide: 2022 Revenue
26 janv. 2023 12h00 HE | EGIDE
Bollène, January 26, 2023 - 06 :00 pm (CET)Press Release 2022 REVENUE Turnover 2022: €33.81 million (+ 4%) Egide SA: +8.9% to €15.46 million, driven by its leading position in the thermal imaging...